반응식
[O:1]=[C:2]1[NH:10][C:5]2=[N:6][CH:7]=[CH:8][CH:9]=[C:4]2[N:3]1[CH:11]1[CH2:16][CH2:15][N:14]([C:17]([O:19][C:20]([CH3:23])([CH3:22])[CH3:21])=[O:18])[CH2:13][CH2:12]1.ClC1C=C(C=CC=1)C(OO)=[O:29]>ClCCCl>[O-:29][N+:6]1[CH:7]=[CH:8][CH:9]=[C:4]2[N:3]([CH:11]3[CH2:12][CH2:13][N:14]([C:17]([O:19][C:20]([CH3:23])([CH3:22])[CH3:21])=[O:18])[CH2:15][CH2:16]3)[C:2](=[O:1])[NH:10][C:5]=12참가 물질
4
실험 절차
2-Oxo-1-(1-t-butoxycarbonylpiperidin-4-yl)-2,3-dihydro-1H-imidazo[4,5-b]pyridine (63 mg, 0.198 mmol) was dissolved in 1,2-dichloroethane (10 mL) and 3-chloroperoxybenzoic acid (137 mg, 0.792 mmol) was added at 0° C. The reaction was warmed to room temperature and stirred for 4 h. The reaction was quenched with saturated aqueous sodium bicarbonate and sodium thiosulfate, extracted with methylene chloride (3×), dried over sodium sulfate, filtered and evaporated to give the title compound (45 mg). MS 335.1 (M+1).
후처리
- customThe reaction was quenched with saturated aqueous sodium bicarbonate and sodium thiosulfate
- extractionextracted with methylene chloride (3×)
- dry with materialdried over sodium sulfate
- filtrationfiltered
- customevaporated
출처 및 근거
- ORD 기록
- ord-45f7672083b245a3912dc1a8f9daa5ea
- 출처 데이터셋
- uspto-grants-2008_11
- 특허 번호
- US07452903B2
연결된 노트
불러오는 중…